Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KLINIK SKOU P/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.8% 0.8%   Bankruptcy risk   4.5% 6.1% 2.6% 2.0% 8.9% 4.6% 15.6% 15.6%   Credit score (0-100)   48 40 61 67 27 45 12 12   Credit rating   BBB BBB BBB A BB BBB BB BB   Credit limit (kDKK)   -0.0 0.0 0.0 0.1 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   440 363 757 818 347 739 0.0 0.0   EBITDA   294 117 307 346 -299 146 0.0 0.0   EBIT   233 9.7 195 245 -392 44.6 0.0 0.0   Pre-tax profit (PTP)   220.9 -14.5 133.6 226.7 -459.4 40.1 0.0 0.0   Net earnings   220.9 -14.5 133.6 226.7 -459.4 40.1 0.0 0.0   Pre-tax profit without non-rec. items   221 -14.5 134 227 -459 40.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   606 499 387 286 193 91.9 0.0 0.0   Shareholders equity total   -750 248 381 608 148 189 -311 -311   Interest-bearing liabilities   1,148 98.7 137 82.5 83.2 82.6 311 311   Balance sheet total (assets)   890 793 988 949 517 628 0.0 0.0   Net Debt   984 -21.4 -310 -372 -47.5 -215 311 311     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   440 363 757 818 347 739 0.0 0.0   Gross profit growth   0.0% -17.5% 108.5% 8.0% -57.6% 112.9% -100.0% 0.0%   Employees   1 1 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 100.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   890 793 988 949 517 628 0 0   Balance sheet change%   389.3% -11.0% 24.6% -3.9% -45.5% 21.5% -100.0% 0.0%   Added value   294.0 116.8 306.6 346.4 -290.9 145.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   517 -214 -223 -203 -185 -203 -92 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   52.8% 2.7% 25.7% 30.0% -113.0% 6.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   16.6% 0.8% 21.9% 25.3% -53.5% 7.9% 0.0% 0.0%   ROI %   17.8% 0.9% 27.3% 30.3% -67.0% 15.4% 0.0% 0.0%   ROE %   41.2% -2.6% 42.5% 45.8% -121.5% 23.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -45.7% 31.2% 38.6% 64.1% 28.7% 30.0% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   334.6% -18.3% -101.1% -107.3% 15.9% -147.2% 0.0% 0.0%   Gearing %   -153.0% 39.9% 36.1% 13.6% 56.1% 43.8% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.0% 3.9% 52.0% 16.7% 81.0% 6.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 0.6 1.3 2.6 0.5 0.8 0.0 0.0   Current Ratio   1.5 1.0 1.5 3.4 0.9 1.1 0.0 0.0   Cash and cash equivalent   164.3 120.1 447.3 454.3 130.7 297.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   83.2 4.0 174.7 423.1 -33.1 25.8 -155.7 -155.7   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   294 117 153 173 -145 73 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   294 117 153 173 -150 73 0 0   EBIT / employee   233 10 97 123 -196 22 0 0   Net earnings / employee   221 -15 67 113 -230 20 0 0